[Corrigendum] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma

Xu,Qiuran; Zhang,Meiqi; Tu,Jianfeng; Pang,Linxiao; Cai,Wenwei; Liu,Xin

doi:10.3892/or.2021.8073

July-2021 Volume 46 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2021 Volume 46 Issue 1

Full Size Image

Correction Open Access

[Corrigendum] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma

Authors:
- Qiuran Xu
- Meiqi Zhang
- Jianfeng Tu
- Linxiao Pang
- Wenwei Cai
- Xin Liu
View Affiliations / Copyright

Affiliations: Department of Emergency, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Neurosurgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China

Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 122
|
Published online on: May 6, 2021

https://doi.org/10.3892/or.2021.8073
Expand metrics +

Article

Oncol Rep 34: [Related article:] 2054-2064, 2015; DOI: 10.3892/or.2015.4175

Following the publication of the above article, an interested reader drew to the authors’ attention that Figs. 6C and 7A apparently contained overlapping panels, suggesting that these data for purportedly different experiments had been derived from the same original source. The wound-healing result for the anti-miR-122+siRNA PKM2 experiment in the lower panel of Fig. 6C and the transwell invasion result for the anti-miR-122+siRNA PKM2 experiment in Fig. 7A were erroneously selected. Accordingly, the authors repeated these assays and were able to confirm that the results were in accordance with the published results.

Figure 6.

MiR-122 regulates the invasion and migration of Hep3B cells by targeting PKM2. (A) Hep3B cells transfected with the negative control and anti-miR-122 were subjected to qRT-PCR for miR-122 (n=6; *P<0.05). (B and C) Wound healing assays revealed that knockdown of miR-122 increased the migration of Hep3B cells, while, siRNA PKM2 was found to reduce the inhibition effect on migration of anti-miR-122 in the Hep3B cells, *P<0.05 by t-test.

Figure 7.

The number of invaded Hep3B cells in the anti-miR-122 group was significantly more than the number in the control group. n=6 repeats with similar results; *P<0.05 by t-test. Data are expressed as the mean ± SEM.

Consequently, the corrected versions of Figs. 6 and 7, containing the replacement data for Figs. 6C and 7A, are shown opposite. It should be emphasized that the inadvertent errors that occurred during the compilation of these figures did not affect the research results or the conclusions of this article. The authors all agree to this Corrigendum, and are grateful to the Editor of Oncology Reports for allowing them to have the opportunity to correct these errors. The authors also apologize to the readership for any inconvenience these errors may have caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma

This article is mentioned in:

Article

Figure 6.

Figure 7.

Related Articles